Form 4: Protara Officer Sells Shares for Tax Obligations
Insider Transaction Report
Protara Therapeutics' Chief Scientific Operations Officer, Jacqueline Zummo, disposed of 6,578 shares of common stock to cover tax liabilities from vested restricted stock units.
Summary
- Jacqueline Zummo, Chief Scientific Operations Officer of Protara Therapeutics, Inc. (TARA), reported a transaction involving the disposition of common stock.
- On January 20, 2026, 6,578 shares of common stock were disposed of at a price of $5.6 per share.
- This disposition represents shares withheld by the Issuer to satisfy income tax obligations.
- The tax obligations are associated with the vesting of Restricted Stock Unit (RSU) Awards granted to Ms. Zummo on January 19, 2023, and January 19, 2024.
- Following this transaction, Ms. Zummo beneficially owns 122,283 shares of Protara Therapeutics common stock directly.
Sentiment
Score: 5
Explanation: The filing reports a routine, non-discretionary insider transaction (sell-to-cover for taxes) which has a neutral impact on the company's outlook or stock sentiment.
Industry Context
This is a routine insider transaction, specifically a 'sell to cover' event, which is common across all industries when restricted stock units or other equity awards vest. It does not reflect a discretionary sale based on the officer's view of the company's future prospects but rather a mandatory action to cover tax liabilities.
Stakeholder Impact
- Shareholders: Minimal impact as this is a routine, non-discretionary transaction for tax purposes and does not signal a change in management's confidence or company fundamentals.
- Employees: No direct impact beyond the reporting person.
Key Dates
| Date | Description |
|---|---|
| 01/19/2023 | Grant date of Restricted Stock Unit Awards to Jacqueline Zummo. |
| 01/19/2024 | Grant date of Restricted Stock Unit Awards to Jacqueline Zummo. |
| 01/20/2026 | Date of transaction where shares were disposed of to satisfy income tax obligations. |
| 01/22/2026 | Date the Form 4 was signed by Jacqueline Zummo. |
Recommendation
holdThis Form 4 filing details a routine 'sell to cover' transaction by an officer to satisfy tax obligations upon RSU vesting. It is a non-discretionary event and does not provide new information regarding the company's operational performance, strategic direction, or future prospects. Therefore, it does not warrant a change in investment recommendation, and a 'hold' stance is maintained based on existing fundamental analysis.
Keywords
Protara Therapeutics, TARA, Form 4, Insider Transaction, Restricted Stock Units, RSU, Tax Withholding, Officer Stock Sale, Jacqueline Zummo
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.